Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Phase II Multicentre Clinical Trial of Single Agent Bortezomib in Patients With Malignant Pleural Mesothelioma

NCT00513877 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT00513877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00513877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Phase II Multicentre Clinical Trial of Single Agent Bortezomib in Patients With Malignant Pleural Mesothelioma
Lead sponsor
Cancer Trials Ireland
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
Not reported
Enrollment
33 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

malignant mesothelioma